Author:
Ahmed Musaab,Ahmed Marium,Mital Dushyant,Ahmed Mohamed H.
Reference127 articles.
1. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial;Aberg;The Lancet. HIV,2017
2. Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks;Aberg;AIDS Research and Human Retroviruses,2012
3. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: The evidence so far and the future challenges;Ahmed;Expert Opinion on Pharmacotherapy,2012
4. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD);Ahmed;Drug Discovery Today,2007
5. HIV metabolic clinic: Can the journey start from a UK clinic to a sub-Saharan African nation?;Ahmed;Journal of Public Health and Emergency,2018